(Total Views: 311)
Posted On: 12/06/2021 1:20:59 PM
Post# of 47
$CTXR News Article - Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma https://marketwirenews.com/news-releases/citi...59614.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
